tiprankstipranks
Advertisement
Advertisement

SANA Stock Latest News

Durable HIP Technology Data De‑Risks Sana Biotechnology’s SC451 Program and Supports Buy Rating
RatingsDurable HIP Technology Data De‑Risks Sana Biotechnology’s SC451 Program and Supports Buy Rating
27d ago
SANA
Sana announces follow-up results from first-in-human study transplanting UP421
PremiumThe Fly
Sana announces follow-up results from first-in-human study transplanting UP421
27d ago
SANA
Sana Biotechnology: Advancing T1D and In Vivo CAR-T Programs with 2026 Catalysts and Solid Cash Runway Supporting Buy Rating
PremiumRatings
Sana Biotechnology: Advancing T1D and In Vivo CAR-T Programs with 2026 Catalysts and Solid Cash Runway Supporting Buy Rating
1M ago
SANA
AI Adoption Exposes Sana Biotechnology to Rising Data, Compliance, and Reputational Risks
PremiumCompany Announcements
AI Adoption Exposes Sana Biotechnology to Rising Data, Compliance, and Reputational Risks
1M ago
SANA
Sana Biotechnology: Emerging Clinical Validation and 2026 Pivotal Milestones Underpin Buy Rating
PremiumRatings
Sana Biotechnology: Emerging Clinical Validation and 2026 Pivotal Milestones Underpin Buy Rating
1M ago
SANA
Sana Biotechnology files automatic mixed securities shelf
PremiumThe FlySana Biotechnology files automatic mixed securities shelf
1M ago
SANA
Sana Biotechnology Updates ATM Program to Support Development
Premium
Company Announcements
Sana Biotechnology Updates ATM Program to Support Development
1M ago
8K
SANA
Sana Biotechnology reports Q4 EPS (16c), consensus (13c)
Premium
The Fly
Sana Biotechnology reports Q4 EPS (16c), consensus (13c)
1M ago
SANA
Sana Biotechnology Names Brian Piper as New CFO
PremiumCompany Announcements
Sana Biotechnology Names Brian Piper as New CFO
2M ago
8K
SANA
Sana Biotechnology appoints Piper as EVP, CFO
PremiumThe Fly
Sana Biotechnology appoints Piper as EVP, CFO
2M ago
SANA
Sana Biotechnology Highlights Diabetes Cell Therapy Advances at Conference
PremiumCompany Announcements
Sana Biotechnology Highlights Diabetes Cell Therapy Advances at Conference
3M ago
8K
SANA
Sana Biotechnology price target raised to $7 from $6 at BofA
PremiumThe Fly
Sana Biotechnology price target raised to $7 from $6 at BofA
3M ago
SANA
Sana Biotechnology announces publication of in vivo gene editing
PremiumThe FlySana Biotechnology announces publication of in vivo gene editing
4M ago
SANA
Sana Biotechnology’s Strategic Focus on T1D Therapies Justifies Buy Rating
Premium
Ratings
Sana Biotechnology’s Strategic Focus on T1D Therapies Justifies Buy Rating
5M ago
SANA
Sana Biotechnology Reports Reduced Losses and Strong Liquidity
Premium
Company Announcements
Sana Biotechnology Reports Reduced Losses and Strong Liquidity
5M ago
SANA
Sana Biotechnology’s Strategic Shift and Financial Positioning Justify Buy Rating
PremiumRatings
Sana Biotechnology’s Strategic Shift and Financial Positioning Justify Buy Rating
5M ago
SANA
Sana Biotechnology reports Q3 EPS (16c), consensus (19c)
PremiumThe Fly
Sana Biotechnology reports Q3 EPS (16c), consensus (19c)
5M ago
SANA
Sana Biotechnology options imply 17.5% move in share price post-earnings
PremiumThe Fly
Sana Biotechnology options imply 17.5% move in share price post-earnings
5M ago
SANA
Sana Biotechnology price target raised to $8 from $5 at Citizens JMP
PremiumThe Fly
Sana Biotechnology price target raised to $8 from $5 at Citizens JMP
5M ago
SANA
Sana Biotechnology Advances CAR-T Therapy with SC262 in Non-Hodgkin’s Lymphoma Study
PremiumCompany AnnouncementsSana Biotechnology Advances CAR-T Therapy with SC262 in Non-Hodgkin’s Lymphoma Study
5M ago
SANA
Sana Biotechnology’s SC291 Study: A Promising Step in Autoimmune Disease Treatment
Premium
Company Announcements
Sana Biotechnology’s SC291 Study: A Promising Step in Autoimmune Disease Treatment
5M ago
SANA
Sana Biotechnology strength attributed to EMJ Capital long call
Premium
The Fly
Sana Biotechnology strength attributed to EMJ Capital long call
6M ago
SANA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >